Whey proteins as source of dipeptidyl dipeptidase IV (dipeptidyl peptidase-4) inhibitorsTULIPANO, Giovanni; SIBILIA, Valeria; MARIA CAROLI, Anna et al.Peptides (New York, NY. 1980). 2011, Vol 32, Num 4, pp 835-838, issn 0196-9781, 4 p.Article

Pleiotropic Mechanisms for the Glucose-Lowering Action of DPP-4 InhibitorsOMAR, Bilal; AHREN, Bo.Diabetes (New York, NY). 2014, Vol 63, Num 7, pp 2196-2202, issn 0012-1797, 7 p.Article

Inhibiteurs des DPP-4 et maladies cardiovasculaires: Les études EXAMINE et SAVORYOMTOV, Bernard.Diabète & obésité. 2013, Vol 8, Num 73, pp 299-300, issn 1957-5238, 2 p.Conference Paper

Sitagliptin, a DPP-4 Inhibitor, Acutely Inhibits Intestinal Lipoprotein Particle Secretion in Healthy HumansCHANGTING XIAO; DASH, Satya; MORGANTINI, Cecilia et al.Diabetes (New York, NY). 2014, Vol 63, Num 7, pp 2394-2401, issn 0012-1797, 8 p.Article

Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiationTHIELITZ, Anja; REINHOLD, Dirk; NEUBERT, Klaus et al.Journal of investigative dermatology. 2007, Vol 127, Num 5, pp 1042-1051, issn 0022-202X, 10 p.Article

Novel Biological Action of the Dipeptidylpeptidase-IV Inhibitor, Sitagliptin, as a Glucagon-Like Peptide-1 SecretagogueSANGLE, Ganesh V; LAUFFER, Lina M; GRIECO, Anthony et al.Endocrinology (Philadelphia). 2012, Vol 153, Num 2, pp 564-573, issn 0013-7227, 10 p.Article

Incrétino-mimétiques et inhibiteurs de la DPP-IV : le point sur les données cliniques : Le GLP-1 dans tous ses états! = Incretin mimetics and DPP-IV inhibitors : focus on the clinical dataMATTA, Maria; GOURDY, Pierre.Métabolismes, hormones, diabètes et nutrition. 2008, Vol 12, Num 1, pp 30-36, issn 1762-3065, 7 p.Article

Alogliptin: A new dipeptidyl peptidase-4 inhibitor for the management of type 2 diabetes mellitusUCHE ANADU NDEFO; OKOLI, Okwuchukwu; EROWELE, Goldina et al.American journal of health-system pharmacy. 2014, Vol 71, Num 2, pp 103-109, issn 1079-2082, 7 p.Article

DPP-4 Inhibitors Repress NLRP3 Inflammasome and Interleukin-1beta via GLP-1 Receptor in Macrophages Through Protein Kinase C PathwayYAO DAI; DONGSHENG DAI; XIANWEI WANG et al.Cardiovascular drugs and therapy. 2014, Vol 28, Num 5, pp 425-432, issn 0920-3206, 8 p.Article

Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetesSUTTON, Jon M; CLARK, David E; DUTTAROY, Alokesh et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 3, pp 1464-1468, issn 0960-894X, 5 p.Article

LE MÉDICAMENT DU MOIS: Linagliptine (Trajenta^®): un inhibiteur sélectif de la DPP-4 à élimination rénale négligeable = LINAGLIPTIN (TRAJENTA^®): A SELECTIVE DPP-4 INHIBITOR WITH LIMITED RENAL ELIMINATIONSCHEEN, A. J; VAN GAAL, L. F.RMLG. Revue médicale de Liège. 2012, Vol 67, Num 2, pp 91-97, issn 0370-629X, 7 p.Article

Reversal of New-Onset Diabetes through Modulating Inflammation and Stimulating β-Cell Replication in Nonobese Diabetic Mice by a Dipeptidyl Peptidase IV InhibitorLEI TIAN; JIE GAO; JIANQIANG HAO et al.Endocrinology (Philadelphia). 2010, Vol 151, Num 7, pp 3049-3060, issn 0013-7227, 12 p.Article

Efficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studiesAHREN, Bo; MATHIEU, Chantal; BADER, Giovanni et al.Diabetologia (Berlin). 2014, Vol 57, Num 7, pp 1304-1307, issn 0012-186X, 4 p.Article

Risk of pancreatitis in patients treated with incretin-based therapiesMEIER, Juris J; NAUCK, Michael A.Diabetologia (Berlin). 2014, Vol 57, Num 7, pp 1320-1324, issn 0012-186X, 5 p.Article

Evaluating Second-Line Treatment Options for Type 2 Diabetes: Focus on Secondary Effects of GLP-I Agonists and DPP-4 InhibitorsBOLAND, Cassie L; DEGEETER, Michelle; NUZUM, Donald S et al.The Annals of pharmacotherapy. 2013, Vol 47, Num 4, pp 490-505, issn 1060-0280, 16 p.Article

Fused bicyclic heteroarylpiperazine-substituted L-prolylthiazolidines as highly potent DPP-4 inhibitors lacking the electrophilic nitrile groupYOSHIDA, Tomohiro; AKAHOSHI, Fumihiko; SAKASHITA, Hiroshi et al.Bioorganic & medicinal chemistry. 2012, Vol 20, Num 16, pp 5033-5041, issn 0968-0896, 9 p.Article

Long-acting peptidomimetics based DPP-IV inhibitorsJADAV, Pradip; BAHEKAR, Rajesh; SHAH, Shailesh R et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 10, pp 3516-3521, issn 0960-894X, 6 p.Article

LA VOIE DU GLP-1: Quelles actions cardiovasculaires ?AVIGNON, Antoine.Cardiologie cardinale. 2012, Vol 6, Num 46, pp 66-69, issn 1960-1646, 4 p.Article

The pharmacokinetics of PF-734200, a DPP-IV inhibitor, in subjects with renal insufficiencyHAIQING DAI; JOHNSON, Susan L; TERRA, Steven G et al.British journal of clinical pharmacology. 2011, Vol 72, Num 1, pp 85-91, issn 0306-5251, 7 p.Article

Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic miceMATSUYAMA-YOKONO, Akiko; TAHARA, Atsuo; NAKANO, Ryosuke et al.Metabolism, clinical and experimental. 2009, Vol 58, Num 3, pp 379-386, issn 0026-0495, 8 p.Article

Influence of TCF7L2 gene variants on the therapeutic response to the dipeptidylpeptidase-4 inhibitor linagliptinZIMDAHL, Heike; ITTRICH, Carina; GRAEFE-MODY, Ulrike et al.Diabetologia (Berlin). 2014, Vol 57, Num 9, pp 1869-1875, issn 0012-186X, 7 p.Article

Probable linagliptin-induced liver toxicity: A case reportKUTOH, E.Diabetes & metabolism. 2014, Vol 40, Num 1, pp 82-84, issn 1262-3636, 3 p.Article

Linagliptine en ajout à l'insuline ^(TRAJENTA°): Repousser les gliptinesLa Revue Prescrire. 2013, Vol 33, Num 361, issn 0247-7750, p. 814Article

GLP-1 receptor agonists or DPP-4 inhibitors: How to guide the clinician?SCHEEN, André J.Annales d'endocrinologie. 2013, Vol 74, Num 5-6, pp 515-522, issn 0003-4266, 8 p.Article

Evaluation of the Pharmacokinetics, Food Effect, Pharmacodynamics, and Tolerability of DA-1229, a Dipeptidyl Peptidase IV Inhibitor, in Healthy Volunteers: First-in-Human StudyKIM, Tae-Eun; KYOUNG SOO LIM; MIN KYU PARK et al.Clinical therapeutics. 2012, Vol 34, Num 9, pp 1986-1998, issn 0149-2918, 13 p.Article